Infusion Therapies
We Offer
List of Therapies
- Cimzia (certolizumab pegol)
- Entyvio (vedolizumab)
- Krystexxa (pegloticase)
- Ocrevus (ocreluizumab) *For MS patients*
- Orencia (abatacept)
- Remicade (infliximab) [+ biosimilars]
- Rituxan (rituximab) [+ biosimilars]
- Saphnelo ( Anifrolumab)
- Simponi Aria (golimumab)
- Stelara (ustekinumab)
- Tepezza (teprotumumab-trbw)
- Uplizna (inebilizumab-cdon)
- Vyvgart (efgartigimod alfa-fcab)
- Cimzia (certolizumab pegol)
- Entyvio (vedolizumab)
- Krystexxa (pegloticase)
- Ocrevus (ocreluizumab) *For MS patients*
- Orencia (abatacept)
- Remicade (infliximab) [+ biosimilars]
- Rituxan (rituximab) [+ biosimilars]
- Saphnelo ( Anifrolumab)
- Simponi Aria (golimumab)
- Stelara (ustekinumab)
- Tepezza (teprotumumab-trbw)
- Uplizna (inebilizumab-cdon)
- Vyvgart (efgartigimod alfa-fcab)
Prepare for Your Therapy Appointment
Infusion medications are prepared at the time of treatment by our experienced and registered nurses. If the medication is intravenous (IV) it will likely be prepared and added to an appropriately sized bag of sterile solution (IV Fluids) which is then administered intravenously through an IV catheter placed by the registered nurse. Some IV and injectable medications come in pre-prepared forms that may not require as much advanced preparation.
You will enter the facility, check-in and you will be seen to the infusion suite.
Infusion therapy times vary depending on the type of treatment, our staff will ensure that the experience is as comfortable for you as possible.
Benlysta (belimumab) | 1 hour 25 minutes |
Cimzia (certolizumab pegol | 30 minutes |
Krystexxa (pegloticase) | 2 hours (with 1 hour observation) |
Orencia (abatacept) | 45 minutes |
Prolia (denosumab) | 15 minutes |
Remicade (infliximab) | 2 hours |
Rituxan (rituxmab) | 4 hours |
Simponi Aria (golimunab) | 40 minutes |
Stelara (ustekinumab | 30 minutes |
Truxima (ritiximab-abbs) | 4 hours |
Entyvio (vedolizumab) | 45 minutes |
Renflexis (infliximab-adba) | 2 hours |
Your doctor will let you know about any driving restrictions. Most patients are able to drive themselves after an infusion. Occasionally there may be a need for the patients to be monitored after their infusions and before discharge from the center.
The infusion tubing is placed in the arm.